RESAPP HEALTH LIMITED – TRADING HALT REQUEST ResApp Health Limited (“Company”) hereby requests that its securities be placed in a trading halt and provides the following information in accordance with ASX Listing Rule 17.1. 1. The Company requests a trading halt immediately, pending the release of an update in relation to the Company's clinical studies. 2. The trading halt is to last until the earlier of the Company releasing the announcement, or the commencement of trading on Wednesday 11 April 2018. 3. We expect that the trading halt will end by the Company making an announcement. 4. The Company is not aware of any reason why the trading halt should not be granted.
RAP Price at posting:
17.5¢ Sentiment: Buy Disclosure: Held
